Biomerica (BMRA) - Get Biomerica, Inc. Report shares soared on Friday after the medical-diagnostics provider said Walmart (WMT) - Get Walmart Inc. Report has begun offering its EZ Detect colorectal-disease-screening test.
The stock of the Irvine, Calif., company recently traded at $5.86, up 30%. They've traded on Friday up as much as 43% at $6.42. The shares had gained 12% in the three months through Thursday.
“The company has now shipped its first orders of EZ Detect to Walmart, and beginning this week, Walmart has begun selling the product through its online sales channel,” Biomerica said.
It’s in the final phase of working with the Bentonville, Ark., retailing giant to sell the EZ Detect product on store shelves.
“In addition, the company is in negotiations with several large partners for distribution of EZ Detect in Asia, Europe and the Middle East,” Biomerica said in a statement.
https://www.thestreet.com/investing/biomerica-colorectal-screening-test-sold-via-walmart
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.